AIIMS
TEVA icon

Analyst IMS Investment Management Services’s Teva Pharmaceuticals TEVA Stock Holding History

Analyst IMS Investment Management Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.7M Hold
2,116,302
– – 1.67% 7
2026
Q1 		$63.7M Hold
2,116,302
– – 1.93% 7
2025
Q4 		$66M Buy
+2,116,302
New +$52.1M 1.93% 6
2018
Q4 		– Sell
-8,781
Closed -$188K – 157
2018
Q3 		$188K Buy
+8,781
New +$204K 0.03% 103
2017
Q3 		– Sell
-9,051
Closed -$300K – 107
2017
Q2 		$300K Buy
9,051
+700
+8% +$21.7K 0.11% 95
2017
Q1 		$269K Buy
8,351
+730
+10% +$24.9K 0.11% 97
2016
Q4 		$276K Sell
7,621
-5,380
-41% -$215K 0.12% 92
2016
Q3 		$599K Sell
13,001
-50
-0.4% -$2.61K 0.25% 68
2016
Q2 		$656K Buy
13,051
+500
+4% +$26.6K 0.28% 61
2016
Q1 		$671K Sell
12,551
-400
-3% -$23.5K 0.29% 64
2015
Q4 		$850K Sell
12,951
-340
-3% -$21K 0.35% 59
2015
Q3 		$751K Sell
13,291
-1,860
-12% -$121K 0.32% 62
2015
Q2 		$895K Sell
15,151
-400
-3% -$24.7K 0.35% 58
2015
Q1 		$969K Sell
15,551
-9,300
-37% -$541K 0.38% 61
2014
Q4 		$1.43M Buy
+24,851
New +$1.38M 0.55% 48

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Analyst IMS Investment Management Services's TEVA Position: Q2 2026 in Review

Analyst IMS Investment Management Services held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 2,116,302 shares worth $71.7M. The position accounts for 1.67% of the portfolio, ranked #7.

Analyst IMS Investment Management Services first reported a position in TEVA in Q4 2014 and has held it in 15 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Analyst IMS Investment Management Services held 2,116,302 shares of Teva Pharmaceuticals worth $71.7M as of Q2 2026.
  • Analyst IMS Investment Management Services left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 1.67% of Analyst IMS Investment Management Services's portfolio in Q2 2026, its #7 holding.
  • Analyst IMS Investment Management Services first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 15 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Analyst IMS Investment Management Services's 13F filing for Q2 2026, filed 29 Jul 2026.